Search Results 111-120 of 15150 for Evening Primrose Oil
The purpose of this study is to determine the maximum tolerated dose (MTD), activity, and safety of oprozomib in patients with hematologic malignancies.
Learn about this common cancer, including information on prevention, symptoms, diagnosis and treatment.
This medicine is also used to treat metastatic NSCLC in patients who have already received EGFR tyrosine kinase inhibitor (TKI) treatment, which did not work.
Understand more about this brain disease that is the most common cause of dementia. Also learn about new tests and medicines.
Mayo Clinic does not endorse companies or products. Advertising revenue supports our not-for-profit mission.
Check out these best-sellers and special offers on books and newsletters from Mayo Clinic Press.
Mayo Clinic researchers drive discoveries that improve detection, diagnosis and treatment. Your quick message to them means so much.